Thomas Rohrer is a Senior Director of Technical Support Bioconjugates at Samsung Biologics. He has an extensive background in the biologics industry, with more than 38 years of experience in biological process development, clinical manufacturing, and licensed biological manufacturing at the National Cancer Institute, Otsuka America Pharmaceutical, Human Genome Sciences (GSK), and Lonza AG. Prior to Samsung, he served in various director positions at Lonza for over 16 years ranging from Director of Biochemical technology/Antibody Drug Conjugates to Director of Project Evaluation and Commercial Development for Bioconjugates. He is an author of numerous publications and articles on biological and bioconjugate manufacturing and technology. Thomas received a B.S. in biochemistry and an M.S. in chemical engineering, with additional graduate studies at RIVM Rijkes Institute voor de Volksgezondheid, Bilthoven, The Netherlands.